Cevimeline HCl
Cevimeline Hydrochloride is a muscarinic agonist with parasympathomimetic activities that is used for the symptomatic treatment of dry mouth in patients with Sjögren’s Syndrome.
Systematic Name
(2R)-5'-methyl-4-azaspiro[bicyclo[2.2.2]octane-2,2'-[1,4]oxathiolane] Hydrochloride
Brand Name(S)
Evoxac
Therapeutic Category
Cholinergic
Suitable Formulations
Solid
Approvals
US DMF
EU-WC